16Jul 2024
Lupin Gets FDA Tentative Nod for Trijardy Equivalent Tablets

Lupin Gets FDA Tentative Nod for Trijardy Equivalent Tablets

Lupin Limited received tentative approval from the USFDA for its generic equivalent of Trijardy XR Extended-Release tablets. The approved tablets, containing Empagliflozin, Linagliptin, and Metformin Hydrochloride, will be manufactured at Lupin's Pithampur facility in India. Dosage strengths approved include 5 mg/2.5 mg/1,000 mg, 10 mg/5 mg/1,000 mg, 12.5 mg/2.5 mg/1,000 mg, and 25 mg/5 mg/1,000 mg.

  • #general surgery
  • #pharmacology
  • #general medicine
  • #psych
  • #rheumatology
  • #pathology
  • #radiology
  • #anaesthesia
  • #psychiatry
  • #fmt
  • #emergency medicine
  • #academics
  • #nursing
  • #pharmacy
  • #trichology
  • #andrology
  • #orthopaedics
  • #critical care
  • #dermatology
  • #dentistry
  • #oncology
  • #business
  • #gastroenterology
  • #nephrology
  • #diagnostics
  • #urology
  • #ophthalmology
  • #gynaecology - ivf
  • #pediatrics
  • #neurology
  • #ent
  • #pulmonology
  • #family health
  • #cardiology
  • #endo-diabetology

Like

Save

Share